C

M

CANNAVÒ , Mariarita

Last name: CANNAVÒ

First name: Mariarita

2022 (v1)

Publication

Metadata-only

Predictors of Serious Adverse Events and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis treated with Obeticholic Acid

De Vincentis, Antonio D'Amato, Daphne Cristoferi, Laura

Obeticholic acid (OCA) has recently been restricted in patients with primary biliary cholangitis (PBC) with "advanced cirrhosis" because of its narrow therapeutic index. We aimed at better defining the predicting factors of hepatic serious adverse events (SAEs) and non-response in cirrhotic patients undergoing OCA therapy.

Uploaded on: February 14, 2024